SILVIA MARÍA
SÁNCHEZ RAMÓN
Profesora asociada de Ciencias de la Salud
EDUARDO
FERNÁNDEZ-CRUZ PÉREZ
Investigador hasta 2016
Publicaciones en las que colabora con EDUARDO FERNÁNDEZ-CRUZ PÉREZ (32)
2016
2014
-
Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion
American Journal of Reproductive Immunology, Vol. 71, Núm. 5, pp. 458-466
2013
-
New decision-tree model for defining the risk of reproductive failure
American Journal of Reproductive Immunology, Vol. 70, Núm. 1, pp. 59-68
-
Sequential combined therapy with Omalizumab and Rituximab: A new approach to severe atopic dermatitis
Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 3, pp. 190-196
2012
-
Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56 + Cells
American Journal of Reproductive Immunology, Vol. 68, Núm. 1, pp. 75-84
-
Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis
PLoS ONE, Vol. 7, Núm. 4
2011
-
Alopecia universal en un adulto tras la vacunación de rutina con toxoide tetánico
Medicina Clinica
-
Estradiol-dependent perforin expression by human regulatory T-cells
European Journal of Clinical Investigation, Vol. 41, Núm. 4, pp. 357-364
-
Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: Immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome
Clinical and Experimental Immunology, Vol. 164, Núm. 1, pp. 100-107
2010
-
IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study
Clinical Immunology, Vol. 134, Núm. 2, pp. 148-157
-
Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy
Rheumatology International, Vol. 30, Núm. 6, pp. 817-819
-
Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab
Archives of Dermatology, Vol. 146, Núm. 12, pp. 1343-1345
2009
-
Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells. Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudinal study
Journal of Neuroimmunology, Vol. 212, Núm. 1-2, pp. 112-120
-
NK cell expansion in obstetrical antiphospholipid syndrome: Guilty by association?
European Journal of Obstetrics and Gynecology and Reproductive Biology
2008
-
Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab
Archives of Dermatology
-
Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after iv methyl-prednisolone for multiple sclerosis relapse
Journal of Neuroimmunology, Vol. 204, Núm. 1-2, pp. 131-135
2007
-
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis
Journal of Neuroimmunology, Vol. 182, Núm. 1-2, pp. 204-211
-
Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss
Fertility and Sterility, Vol. 87, Núm. 4, pp. 976.e17-976.e18
2006
-
Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis
Journal of Rheumatology, Vol. 33, Núm. 8, pp. 1476-1481
-
Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis
Arthritis Care and Research, Vol. 55, Núm. 4, pp. 657-661